FYI - For Your Innovation

FYI - For Your Innovation


Coronavirus and the Future of Immunotherapy with Prof. Isaiah Arkin

March 02, 2020

The Coronavirus (COVID-19) is dominating most headlines of every news channel in the world. To learn more about this virus and its implications we talked to Professor Isaiah Arkin. He is the Arthur Lejwa Prof. of Structural Biochemistry at Hebrew University of Jerusalem and the former Vice-President for Research and Development at the University. He holds a Ph.D. from the Yale School of Medicine in Cell Biology. Professor Arkin’s research has succeeded in shedding new light on the inner workings of flu viruses and in particular how a virus avoids anti-viral therapy.
In this episode, Prof. Arkin clarifies some of the misconceptions around the coronavirus and draws parallels between the common flu and SARS. We discuss the threat level of the coronavirus, what we can expect from the disease, how we can control it, and whether the global fear is justified. In the second part of the show, we discuss immunotherapy, which he believes is ‘the next big thing’ in healthcare. He walks us through what the future of cancer research holds, why we should look to the natural world for answers and highlights some interesting research that is currently happening. As usual, our interaction with the Hebrew University was a fruitful one and we look forward to engaging more at NEXUS: Israel 2020 in New York.